valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

BUDA JUICE, INC. (BUDA) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$1.45 ComplexitySimple Updated
$0.80 $3.46
bear $0.80 base $2.52 bull $3.46 margin of safety $1.45 market price* $7.50
Buda Juice makes cold-pressed, always-refrigerated citrus juices, lemonades, limeades and organic wellness shots in Dallas and sells them to grocery retailers, under its own Buda Juice and Buda Fresh brands and as private label. Products have an 8-12 day shelf life and are kept cold from fruit to shelf. It converted from a Texas LLC to a Delaware corporation on January 1, 2026 and went public on January 9, 2026, raising about $23 million, while 500,000 shares held by an existing owner were bought back at the $7.50 IPO price. The single most important fact about this business is that one grocery customer, which the filings do not name, bought 97% of everything it sold in 2025 and 95% in 2024. In the first half of 2026 that fell to about 90% as Buda Fresh went into Walmart stores in nine states. Sales are made on electronic purchase orders through an EDI system, not under a long-term supply contract, so that customer could cut or end its orders with little notice. Earnings. The business has only two audited years, both as an LLC that paid no entity-level income tax. Cash from operations, after removing working-capital swings and the modest equipment spending needed to keep the plant running, was about $3.56 million in 2024 and $3.58 million in 2025 on sales of $11.3 million and $12.6 million. We stripped out about $0.5 million of IPO costs paid ahead of the offering in 2025 and about $0.25 million of one-time insurance money in 2024, and treated about $0.4 million of 2024 plant-expansion spending as growth rather than upkeep. That private-company, pre-tax figure no longer describes the business. As a public C-corporation it now pays roughly 25% income tax and carries public-company costs: selling and administrative expense ran $1.06 million in the second quarter of 2026 against $0.38 million a year earlier. First-half 2026 sales rose 22% to $8.0 million, but gross margin fell from 46% to 38% on diesel-driven freight, an interim outside co-packer for the new dressings line, and produce costs; net income was $858,000 after a one-time $182,000 deferred-tax charge from the conversion. Rebuilding the half on our basis (net income before that charge, plus depreciation, less upkeep spending, with stock awards counted as dilution rather than expense) gives about $1.27 million. The first half has historically carried about 56% of the year's earnings, which points to roughly $2.3 million a year, but the second quarter's higher administrative run-rate applied to a full year takes off about $0.3 million after tax. We therefore use about $2.0 million a year of after-tax owner earnings as today's normal level. Owner earnings were essentially flat in 2025 (up under 1%); the base case's rise in years two and three rests only on the Walmart rollout that was already in stores by the second quarter of 2026. Stock awards. In April 2026 directors and officers received restricted stock units worth about $15.9 million at $10.50 a share ($15.6 million still unrecognized at June 30), vesting from January 2027 over up to three years. That is roughly 1.5 million shares, about 12% of the company. We count them as dilution rather than a yearly expense, so all per-share values use about 14.4 million shares (12.57 million outstanding plus those units and about 290,000 warrants). Balance sheet. The company has no borrowings; its $3 million Amegy Bank credit line is undrawn. It held $18.8 million of cash at June 30, 2026. We keep about $2 million back for operations and count the rest, about $16.8 million, as surplus. Leases run through operating cash flow and are not subtracted. Base case ($2.52 per share). Owner earnings of $2.0 million in the first year, about $2.2 million for two years as the Walmart rollout fills out a full year, then back to $2.0 million as freight, produce and private-label competition hold margins. We credit no further customers, states or products because none are signed. We assume the large customer keeps buying at roughly today's level, as it has for years, but because nothing contractual guarantees it we hold earnings flat for fifteen years and then fade them to zero over the next decade. Management plans regional production plants with IPO money but has given no cost or timetable; we assume about $3 million of cash is spent on them and earns nothing yet visible. The business is worth about $22.5 million, plus $13.8 million of surplus cash, with no debt: about $36.3 million, or $2.52 a share. Bull case ($3.46 per share). The Walmart business ramps and holds and the 2026 gross-margin dip reverses as produce and freight costs normalize, lifting earnings to about $2.7 million by year four and holding there for twenty years before fading. No plant spending is wasted. The business is worth about $33.0 million plus $16.8 million of surplus cash, no debt: about $49.8 million, or $3.46 a share. National expansion and new categories were not credited because nothing about them is contracted. Bear case ($0.80 per share). Single-customer dependence is the named, evidenced risk, and grocers do reset suppliers and move private label to cheaper sources. Earnings stay near $1.6 million for two years; in year three the main customer moves its private-label juice elsewhere and halves its orders. With a fixed plant and public-company costs spread over much smaller sales, the business loses about $0.5 million a year for three years, then earns about $0.3 million a year from Walmart and branded sales for five years before the story ends. Meanwhile about $8 million of cash is spent on regional plants that never earn a return. The business is worth about $2.7 million plus about $8.8 million of remaining surplus cash, no debt: about $11.5 million, or $0.80 a share. Even here the company owes nothing to lenders; most of what is left is cash. Changes since our previous analysis a few days ago: nothing new has been filed, and the values are essentially unchanged. A recheck of the arithmetic trims the base and bull figures by a few cents. Margin of safety price ($1.45). How sure are we of the earnings level? Not very: two audited years, both as a tax-free private company, and one half-year as a public company that already shows margin pressure. The worst plausible event is losing most of the main customer, which no contract prevents; the company would survive it because it has no debt and a large cash balance, but most of its earning power would go. If we are wrong about that customer and about whether the regional plants earn anything, the shares are worth roughly the surplus cash, about $1.17 a share. The company pays no dividend, so nothing is paid during the holding period, and the price assumes a holding period of three years or more. The margin-of-safety price of $1.45 values the business at about $4 million beyond the surplus cash for a business earning about $2 million a year after tax; if the base case plays out over three years it implies a return above the 20% target, and in the bear case the cash absorbs most of the shortfall. Above that price, too much of the outcome rests on one customer's purchase orders. What would make this wrong: a signed multi-year supply agreement with the main customer, or new customers bringing its share well below half of sales, would raise the value; a cut in that customer's orders, gross margins staying below 40%, or large plant spending without new contracts would lower it.
Fiscal yearOwner's earningsMethodology
2025 $0.36 ▼
OE = CFO - dWC - SBC - maintenance capex. FY2025: CFO=$3,150K; working-capital changes per cash-flow reconciliation (AR +8, inventory +26, prepaids -605 incl. ~$503K IPO costs temporarily capitalized, AP/other current liabilities -54) = -$625K, removed so CFO-dWC=$3,775K; SBC=$0; capex=$246K; capex_ratio=mean(684/11,274, 246/12,609)=4.01%; growth capex=4.01% x (12,609-11,274)=$54K; maintenance capex=$192K; OE=$3,583K. Reconciliation: NI $3,533K + D&A $239K + ROU amortization $123K - operating lease payments $120K - maint capex $192K = $3,583K (0% gap). Company was a pass-through LLC (income tax $0), so OE is before entity-level income tax; converted to C-corp 1/1/2026. Shares: as-converted pre-IPO common shares 10,000,333 (XBRL diluted 14,000 LLC units not usable). OE/sh=$0.358. Interest paid $0 (no line-of-credit balance). Source: FY2025 10-K, accession 0001493152-26-012988.
2024 $0.36 ▼
OE = CFO - dWC - SBC - maintenance capex. FY2024: CFO=$3,974K; working-capital changes per cash-flow reconciliation (AR -28, inventory +34, prepaids -46, AP/other current liabilities +171) = +$131K, removed so CFO-dWC=$3,843K; SBC=$0 (no equity awards outstanding as an LLC); capex=$684K, of which ~$400K was disclosed in MD&A as one-time manufacturing-facility expansion (FY2023 revenue not available in XBRL for the formula, so disclosed expansion spend used as growth capex), maintenance capex=$284K; OE=$3,559K. Reconciliation: NI $3,574K + D&A $274K + ROU amortization $108K - operating lease payments $113K - maint capex $284K = $3,559K (0% gap). Note: FY2024 included ~$252K one-time insurance proceeds; company was a pass-through LLC, so OE is before entity-level income tax. Shares: XBRL diluted count (14,000 LLC units) is pre-conversion; used as-converted pre-IPO common shares of 10,000,333 (12,567,000 outstanding post-IPO less 2,666,667 IPO shares less 399,999 over-allotment plus 500,000 redeemed). OE/sh=$0.356. Interest paid $89K. Source: FY2025 10-K, accession 0001493152-26-012988.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States, almost entirely Texas (South) through one grocery retailer, with the Buda Fresh line distributed into Walmart stores in nine states beginning in the second quarter of 2026.
Historical growth strategy
Organic growth by deepening a single grocery-retail relationship with private-label and own-brand cold-pressed juices, lemonades and wellness shots out of one Dallas plant, expanding plant capacity as orders grew; since the January 2026 IPO it has added Walmart distribution in nine states and a dressings line, and says it plans regional production plants funded by IPO cash.
Chart analysis
A chartist would see a very short trading history: the stock listed on Nasdaq in January 2026 at a $7.50 IPO price and moved above it in the spring (insider stock awards in April were priced at $10.50), followed by choppy action. With under a year of data there is no established long-term trend, support or resistance beyond the IPO price itself, which most chartists would treat as the key level to watch; with so little history, any breakout or breakdown signal is unreliable.
Competitors

Companies we consider competitors of BUDA. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.